BriaCell Therapeutics Corp. (BCTX), a clinical-stage biotechnology company, on Tuesday reported durable and sustained complete resolution of a lung metastasis in a patient with metastatic breast cancer treated with its off-the-shelf immunotherapy candidate Bria-OTS.
Following the promising report for Bria-OTS, BCTX shares surged 50% to $11 in the pre-market.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.